Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE2 production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity

BMB Reports

Volumn 47, Issue 1, 2014, Pages 45-50

  Duan, Yuzhong ^a   Chen, Fanglin ^a   Zhang, Anmei ^a   Zhu, Bo ^a   Sun, Jianguo ^a   Xie, Qichao ^a   Chen, Zhengtang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Alveolar macrophages; Protein kinase C; Protein tyrosine phosphatase

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXOVANADATE; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE; PTGS2 PROTEIN, HUMAN; VANADIC ACID;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; LUNG ALVEOLUS MACROPHAGE; METABOLISM; SWINE; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE 2; DINOPROSTONE; HYPOGLYCEMIC AGENTS; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; NF-KAPPA B; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASES; RNA, MESSENGER; SWINE; UP-REGULATION; VANADATES;

EID: 84893370424     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2014.47.1.089     Document Type: Article

References (29)

1. Leikauf, G. D., McDowell, S. A., Wesselkamper, S. C., Hardie, W. D., Leikauf, J. E., Korfhagen, T. R. and Prows, D. R. (2002) Acute lung injury: functional genomics and genetic susceptibility. Chest 121, 70S-75S.
2. Matute-Bello, G., Frevert, C. W. and Martin, T. R. (2008) Animal models of acute lung injury. Am. J. Physiol. Lung. Cell Mol. Physiol. 295, L379-399.
3. Rocco, P. R. and Pelosi, P. (2008) Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality? Curr. Opin. Crit. Care. 14, 50-55.
4. Sibille, Y. and Reynolds, H. Y. (1990) Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141, 471-501.
5. Hualin, C., Wenli, X., Dapeng, L., Xijing, L., Xiuhua, P. and Qingfeng, P. (2012) The anti-inflammatory mechanism of heme oxygenase-1 induced by hemin in primary rat alveolar macrophages. Inflammation 35, 1087-1093.
6. McCourtie, A. S., Merry, H. E., Farivar, A. S., Goss, C. H. and Mulligan, M. S. (2008) Alveolar macrophage secretory products augment the response of rat pulmonary artery endothelial cells to hypoxia and reoxygenation. Ann. Thorac. Surg. 85, 1056-1060.
7. Gust, R., Kozlowski, J. K., Stephenson, A. H. and Schuster, D. P. (1999) Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. Am. J. Respir. Crit. Care. Med. 160, 1165-1170.
8. Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., Van De Putte, L. B. and Lipsky, P. E. (1998) Cyclooxygenase in biology and disease. FASEB J. 12, 1063-1073.
9. Goggel, R., Hoffman, S., Nusing, R., Narumiya, S. and Uhlig, S. (2002) Platelet-activating factor-induced pulmonary edema is partly mediated by prostaglandin E(2), E-prostanoid 3-receptors, and potassium channels. Am. J. Respir. Crit. Care. Med. 166, 657-662.
10. Riese, J., Hoff, T., Nordhoff, A., DeWitt, D. L., Resch, K. and Kaever, V. (1994) Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J. Leukoc. Biol. 55, 476-482.
11. Jin, S. W., Zhang, L., Lian, Q. Q., Liu, D., Wu, P., Yao, S. L. and Ye, D. Y. (2007) Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1. Anesth. Analg. 104, 369-377.
12. Looney, M. R., Nguyen, J. X., Hu, Y., Van Ziffle, J. A., Lowell, C. A. and Matthay, M. A. (2009) Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J. Clin. Invest. 119, 3450-3461.
13. Xu, X. M., Sansores-Garcia, L., Chen, X. M., Matijevic-Aleksic, N., Du, M. and Wu, K. K. (1999) Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc. Natl. Acad. Sci. U. S. A. 96, 5292-5297.
14. Kwon, K. S. and Chae, H. J. (2003) Sodium salicylate inhibits expression of COX-2 through suppression of ERK and subsequent NF-kappaB activation in rat ventricular cardiomyocytes. Arch. Pharm. Res. 26, 545-553.
15. Mifflin, R. C., Saada, J. I., Di Mari, J. F., Valentich, J. D., Adegboyega, P. A. and Powell, D. W. (2004) Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts. Mol. Pharmacol. 65, 470-478.
16. Giroux, M. and Descoteaux, A. (2000) Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha. J. Immunol. 165, 3985-3991.
17. Karin, M. (1999) How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18, 6867-6874.
18. Yamaguchi, T., Miyata, Y., Hayamizu, K., Hashizume, J., Matsumoto, T., Tashiro, H. and Ohdan, H. (2012) Preventive effect of G-CSF on acute lung injury via alveolar macrophage regulation. J. Surg. Res. 178, 378-384.
19. Wang, B., Gong, X., Wan, J. Y., Zhang, L., Zhang, Z., Li, H. Z. and Min, S. (2011) Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm. Pharmacol. Ther. 24, 434-441.
20. Shin, Y. W., Bae, E. A., Kim, S. S., Lee, Y. C. and Kim, D. H. (2005) Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Int. Immunopharmacol. 5, 1183-1191.
21. Du, J., Cheng, B., Zhu, X. and Ling, C. (2011) Ginsenoside rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects. J. Immunol. 187, 942-950.
22. Hsieh, H. L., Wang, H. H., Wu, C. Y., Jou, M. J., Yen, M. H., Parker, P. and Yang, C. M. (2007) BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes. Cell Signal. 19, 330-340.
23. Liu, S., Feng, G., Wang, G. L. and Liu, G. J. (2008) p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Eur. J. Pharmacol. 584, 159-165.
24. Xia, Y. F., Ye, B. Q., Li, Y. D., Wang, J. G., He, X. J., Lin, X., Yao, X., Ma, D., Slungaard, A., Hebbel, R. P., Key, N. S. and Geng, J. G. (2004) Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J. Immunol. 173, 4207-4217.
25. Stark, L. A., Din, F. V., Zwacka, R. M. and Dunlop, M. G. (2001) Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J. 15, 1273-1275.
26. Muller, D. N., Heissmeyer, V., Dechend, R., Hampich, F., Park, J. K., Fiebeler, A., Shagdarsuren, E., Theuer, J., Elger, M., Pilz, B., Breu, V., Schroer, K., Ganten, D., Dietz, R., Haller, H., Scheidereit, C. and Luft, F. C. (2001) Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage. FASEB J. 15, 1822-1824.
27. Grilli, M., Pizzi, M., Memo, M. and Spano, P. (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274, 1383-1385.
28. Wensvoort, G., Terpstra, C., Pol, J. M. A., ter Laak, E. A., Bloemraad, M., de Kluyver, E. P., Kragten, C., van Buiten, L., den Besten, A., Wagenaar, F., Broekhuijsen, J. M., Moonen, P. L. J. M., Zetstra, T., de Boer, E. A, Tibben, H. J., de Jong, M. F., van't Veld, P., Greenland, G. J. R., van Gennep, J. A., Voets, M. Th., Verheijden, J. H. M. and Braamskamp, J. (1991) Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet. Q. 13, 121-130.
29. Singh, S. and Aggarwal, B. B. (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J. Biol. Chem. 270, 24995-25000.